TrialBMC urology2017

Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study.

Hao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.